// App-Quantinova.ai

SAT0513 (2018) : Progressive skin fibrosis is associated with a decline in lung function and poorer survival in patients with diffuse cutaneous systemic sclerosis: a european scleroderma trials and research (EUSTAR analysis

Researchers

Presenter

  • W. Wu

Principal Investigators

  • S. Jordan

  • N. Graf

  • J. Pena

  • J. Curram

  • Y. Allanore

  • M. Matucci-Cerinic

  • J.E. Pope

  • C. Denton

  • D. Khanna

  • O. Distler

Medical Centers

  • University Hospital of Zurich, Zurich, Switzerland

  • graf biostatistics, Winterthur, Switzerland

  • Bayer US, LLC, Parsippany, NJ

  • Bayer Plc, Reading, UK

  • Cochin Teaching Hospital, AP-HP, Paris Descartes University, Paris, France

  • University of Florence, Florence, Italy

  • University of Western Ontario, St Joseph's Health Care, London,Canada

  • University College London, Royal Free Campus, London,

  • University of Michigan, Ann Arbor, MI

Locations

  • Switzerland

  • United States

  • United Kingdom

  • France

  • Italy

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Hypertension

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Actelion Pharmaceuticals US, Inc.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved